Skip to content

IV and Intrathecal Ketamine in Cesarean Section

Comparison Between the Analgesic Effects of Intrathecal Versus Intravenous Ketamine After Spinal Anaesthesia for Elective Caesarean Delivery :a Randomised Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05679375
Enrollment
60
Registered
2023-01-11
Start date
2023-02-01
Completion date
2024-10-31
Last updated
2025-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Cesarean Section

Brief summary

In the current study, the investigators will compare the effects of low-dose intravenous (i.v.) ketamine versus intrathecal Ketamine added to spinal anesthesia on the time to first request for analgesia and maternal pain scores and overall satisfaction in patients undergoing cesarean section.

Interventions

Patients will receive intrathecal Ketamine 0.1mg/kg added to bupivacaine and morphine

Patients will receive IV Ketamine 0.25mg/kg after spinal

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

• Pregnant undergoing elective cesarean section

Exclusion criteria

* Significant coexisting diseases (pregnancy-induced hypertension or diabetes) * body mass index ≥40kg/m2, height \<150cm * Current use of pain medication including opioids * history of substance abuse or hallucinations, cardiovascular disease, diabetes, multiple gestations * chronic pain was excluded. * contraindications to spinal anaesthesia, * severely compromised fetus requiring general anesthesia and those patients who received labor analgesia

Design outcomes

Primary

MeasureTime frame
Time to the first analgesic requestFirst Postoperative day

Secondary

MeasureTime frame
Postoperative pain scores NRS at rest and on movement; (2, 4, 6, 12, and 24 hours) postoperativefirst postoperative day

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026